Literature DB >> 2864028

Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics.

H E Spohn, L Coyne, R Lacoursiere, D Mazur, K Hayes.   

Abstract

Relationships of neuroleptic dosage and tardive dyskinesia with measures of attentional, information-processing, and psychophysiological dysfunctions in medicated chronic schizophrenics were explored by correlational and stepwise multiple-regression analysis. High neuroleptic dosage was found to be associated with increased reaction time, reduced span of apprehension, low basal skin conductance level, and reduced skin conductance reactivity. Severe abnormal involuntary movements were associated with increased eye-tracking dysfunction, increased scanning eye-movement rate, increased reaction time, and reduced skin conductance reactivity. These findings led to the hypothesis that neuroleptic dosage and tardive dyskinesia may be sources of error variance in the measurement of attentional, information-processing, and psychophysiological functions in schizophrenics.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2864028     DOI: 10.1001/archpsyc.1985.01790320017003

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  6 in total

Review 1.  Effects of neuroleptics on electrodermal activity in schizophrenic patients: a review.

Authors:  D B Schnur
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Chronic neuroleptic effects on spatial reversal learning in monkeys.

Authors:  E D Levin; L M Gunne
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Impaired performance in a saccadic tracking task in schizophrenic patients.

Authors:  F M Reischies; R D Stieglitz; A Mielewczyk; A Vogel
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

4.  The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia.

Authors:  Gabriel Selva-Vera; Vicent Balanzá-Martínez; José Salazar-Fraile; José Sánchez-Moreno; Anabel Martinez-Aran; Patricia Correa; Eduard Vieta; Rafael Tabarés-Seisdedos
Journal:  BMC Psychiatry       Date:  2010-06-15       Impact factor: 3.630

Review 5.  Pharmacological treatment effects on eye movement control.

Authors:  James L Reilly; Rebekka Lencer; Jeffrey R Bishop; Sarah Keedy; John A Sweeney
Journal:  Brain Cogn       Date:  2008-12       Impact factor: 2.310

6.  Association of tardive dyskinesia with increased frequency of eye movement disturbances in chronic schizophrenic patients. A clinical note.

Authors:  G Oepen; U Thoden; C Warmke
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1990
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.